Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Abatacept may help some people with alopecia areata regrow hair.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

RTA 408 cream protects mice from radiation skin damage.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Entospletinib effectively prevents eye and skin GVHD in mice.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.